Merit Medical Systems (MMSI) Tops Q2 EPS by 3c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Merit Medical Reports Record Revenues for Second Quarter of 2018; Merit Adjusts 2018 Guidance
July 23, 2018 4:01 PM EDTQ2 2018 worldwide revenue of $224.8 million ($221.2 million on a comparable, constant currency* basis), up 20.5% as reported (up 18.6% on a comparable, constant currency* basis) over Q2 2017Q2 2018 core revenue* up 11.7% over Q2 2017 core revenue* (core revenue* up 9.8% on a comparable, constant currency* basis)Q2 2018 GAAP EPS was $0.21, compared to $0.19 in Q2 2017; Q2 2018 non-GAAP EPS* was $0.43, compared to $0.36 in Q2 2017Q2 2018 GAAP gross margin was 44.5%, compared to 45.1% in Q2 2017; Q2 2018 non-GAAP gross margin* was 48.9%, compared to 48.3% for Q2 2017Q2 2018 non-GAAP gross margin* was up 140 basis points compared to Q1 2018
... More
